Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease

World Journal of Gastroenterology

Volumn 19, Issue 32, 2013, Pages 5381-5384

  Cerda, Cristian ^a,b   Bruguera, Miguel ^a,b   Parés, Albert ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chondroitin sulphate; Glucosamine; Hepatotoxicity; Osteoarthritis; Toxic hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHONDROITIN SULFATE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSAMINE;

AGED; ARTICLE; CASE REPORT; CHRONIC LIVER DISEASE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; HYPERTRANSAMINASEMIA; LIVER TOXICITY; SKIN MANIFESTATION; ADULT; COMPLICATION; DIET SUPPLEMENTATION; DRUG-INDUCED LIVER INJURY; LIVER FUNCTION TEST; MALE; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHONDROITIN SULFATES; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; FEMALE; GLUCOSAMINE; HEPATITIS C, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84883019934     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i32.5381     Document Type: Article

References (12)

1. Vista ES, Lau CS. What about supplements for osteoarthritis? A critical and evidenced-based review. Int J Rheum Dis 2011; 14: 152-158 [PMID: 21518314 DOI: 10.1111/j.1756-185X.2011.01619.x]
2. Owens S, Wagner P, Vangsness CT. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg 2004; 17: 185-193 [PMID: 15553585]
3. Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother 1998; 32: 574-579 [PMID: 9606479 DOI: 10.1345/aph.17235]
4. Ossendza RA, Grandval P, Chinoune F, Rocher F, Chapel F, Bernardini D. [Acute cholestatic hepatitis due to glucosamine forte]. Gastroenterol Clin Biol 2007; 31: 449-450 [PMID; 17483788 DOI: 10.1016/S0399-8320(07)89410-3]
5. Smith A, Dillon J. Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies. BMJ Case Rep 2009; 2009: 1603 [PMID: 21887162 DOI: 10.1136/bcr.02.2009.1603]
6. Linnebur SA, Rapacchietta OC, Vejar M. Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy 2010; 30: 750, 258e-262e [PMID: 20586134 DOI: 10.1592/phco.30.7.750]
7. Kirkham SG, Samarasinghe RK. Review article: Glucosamine. J Orthop Surg (Hong Kong) 2009; 17: 72-76 [PMID: 19398798]
8. Huskisson EC. Glucosamine and chondroitin for osteoarthritis. J Int Med Res 2008; 36: 1161-1179 [PMID: 19094424 DOI: 10.1177/147323000803600602]
9. Simánek V, Kren V, Ulrichová J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 51-56 [PMID: 16170388 DOI: 10.5507/bp.2005.004]
10. Wabndel S, Juni P, Tendal, Nuesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010; 341: c4675 [DOI: 10.1136/bmj.c4675]
11. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Reda DJ, Moskowitz RW, Williams HJ, Clegg DO. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008; 58: 3183-3191 [PMID: 18821708 DOI: 10.1002/art.23973]
12. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005; 18: CD002946 [PMID: 15846645]